Variable | Subset | Hazard ratio (95%) CI | P value |
---|---|---|---|
Univariate analysis (n = 507) |  |  |  |
Hsp70 membranal and cytoplasmic staining | low vs. high | 0.540 (0.390-0.747) | <0.001 |
Hsp70 nucleus staining | low vs. high | 1.708 (1.241-2.351) | 0.001 |
Age | <46 vs. > = 46 | 1.644 (1.202-2.249) | 0.002 |
Sex | male vs. female | 0.827 (0.574-1.192) | 0.308 |
T stage | T1 + T2 vs. T3 + T4 | 3.149 (2.159-4.594) | <0.001 |
N stage | N0 vs. N1 + N2 + N3 | 2.474 (1.592-3.846) | <0.001 |
Recurrence or metastasis | No vs. Yes | 548.914 (76.728-3.927E3) | <0.001 |
Clinical stage | I + II vs. III + IV | 6.034 (3.352-10.862) | <0.001 |
Multivariate analysis (n = 507) |  |  |  |
Hsp70 cytoplasmic and membranal staining | low vs. high | 0.529 (0.360-0.778) | 0.001 |
Hsp70 nuclear staining | low vs. high | 2.601 (1.785-3.789) | 6.41E-07 |
Clinical stage | I + II vs. III + IV | 3.641 (1.623-8.170) | 0.002 |